Artificial Intelligence in breast cancer screening – part 2: international differences
Previously we reported on a major study evaluating AI as a tool to identify breast cancer on mammography. The results were impressive. In the UK, […]
Previously we reported on a major study evaluating AI as a tool to identify breast cancer on mammography. The results were impressive. In the UK, […]
Despite many technological advances in mammographic imaging over the last century, breast cancer screening is largely the same as it was when first studied 60 […]
As the year draws to an end, we have been looking back and reflecting on the groups achievements in 2019. We decided that the best […]
In this post Georgia Mannion-Krase (@GeorgiaMKrase) updates us on events at the E-Cigarette (EC) Summit held at the Royal Society on the 14th November 2019. […]
Changing burdens of disease When we discuss the burden of disease in regions such as Sub-Saharan Africa (SSA), our mind immediately jumps to examples such […]
We have all heard how cancer outcomes are poorer for people in low socioeconomic groups and those from ethnic minority backgrounds. Although I knew that […]
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Deep down every epidemiologist imagines themselves as Sherlock Holmes: equipped with little more than a magnifying glass and a good brain, they dream of becoming […]
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Clinical predictions are based on past experiences of a given population. In this post David Armstrong, Professor of Medicine and Sociology at King’s College London […]
Copyright © 2024 | WordPress Theme by MH Themes